PSC - Primary Sclerosing Cholangitis
PHASE 2 TREATMENT TRIAL
PSC EDP 305-201
Title: A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adult Subjects With Primary Sclerosing Cholangitis (PSC)
Condition & Intervention: PSC: HTD1801 (oral)
PI: Landis
Site: HMC